Skip to content

Gyrus ACMI 890919Recalls & reported problems

Gyrus ACMI, LLC · BIVALVE SPLINT, LARGE THICK. SHORT-TERM USE UP TO 14 DAYS .50 MM UHMWPE (12/PK) · Class 1

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00821925040311), received between Feb 22, 2022 and Feb 22, 2022 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Perforation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 22, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE CUSTOMER REPORTED THE LACK OF FLEXIBILITY OF THE SPLINT WHICH CAUSED A PERFORATION OF THE NASAL SEPTUM WITH NECROSIS OF THE CARTILAGE. NO ADDITIONAL INFORMATION HAS BEEN PROVIDED TO DATE.

    Patient problems: Perforation

    MAUDE report 13581159 ↗

Other SPLINT, INTRANASAL SEPTAL devices

All SPLINT, INTRANASAL SEPTAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page